Structure-Based Drug Design 2013

At CHI/Bio-IT World's thirteenth annual Structure-Based Drug Design conference, you will hear about developments in in silico technology, as well as experimental approaches useful for accurately predicting and modeling the structures of proteins in structure-based drug design efforts. In addition, examples of successful applications of such technology approaches to genome-to-drug lead investigations will be addressed.

Reasons to Attend:
• HEAR about novel ligand-centric approach for force field calculation.
• BE inspired to set up ambitious projects on SBDD using automated analytics pipeline and long-timescale explicit molecular simulation.
• EXAMINE the role of water/solvent in structure-based drug design.
• RE-DISCOVER the potential of fragment-based drug design through simulation of the complete binding process.
• EXPLORE the epigenomic protein landscapes of cancer cells for drug design.
• MEET potential collaborators from both academic and industry practitioners.

Sessions:
• Structure-Based Drug Design for Kinase
• Drug Resistance
• Force Field Calculation
• GPCR
•  Water & Solvation in Drug Design
•  Fragment-Based Drug Design
• Protein-Protein Interaction
• Epigenetic Targeting